Net profit of Mercury Laboratories rose 416.22% to Rs 1.91 crore in the quarter ended March 2024 as against Rs 0.37 crore during the previous quarter ended March 2023. Sales declined 10.60% to Rs 17.37 crore in the quarter ended March 2024 as against Rs 19.43 crore during the previous quarter ended March 2023.For the full year,net profit rose 1.25% to Rs 5.65 crore in the year ended March 2024 as against Rs 5.58 crore during the previous year ended March 2023. Sales rose 0.31% to Rs 75.56 crore in the year ended March 2024 as against Rs 75.33 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales17.3719.43 -11 75.5675.33 0 OPM %15.315.35 -11.9511.36 - PBDT2.971.37 117 9.749.92 -2 PBT2.250.75 200 6.927.44 -7 NP1.910.37 416 5.655.58 1 Powered by Capital Market - Live News

Mercury Laboratories announced that the Board of Directors of the Company at its meeting held on 28 May 2024, has recommended a Final dividend of Rs.3.5 per share (i.e.35%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 28 May 2024Powered by Capital Market - Live News

Net profit of Mercury Laboratories rose 103.28% to Rs 1.24 crore in the quarter ended December 2023 as against Rs 0.61 crore during the previous quarter ended December 2022. Sales rose 5.42% to Rs 17.11 crore in the quarter ended December 2023 as against Rs 16.23 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales17.1116.23 5 OPM %13.033.57 - PBDT2.311.08 114 PBT1.590.45 253 NP1.240.61 103 Powered by Capital Market - Live News

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News